Bvf Inc Akero Therapeutics, Inc. Transaction History

Bvf Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$19.25 - $26.76 $5.45 Million - $7.57 Million	-282,862 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$12.8 - $27.05 $2.15 Million - $4.55 Million	-168,147 Reduced 37.28%	282,862 $6 Million
Q4 2019 Feb 14, 2020	SELL	$17.37 - $27.27 $360,201 - $565,497	-20,737 Reduced 4.4%	451,009 $10 Million
Q3 2019 Nov 14, 2019	SELL	$16.89 - $29.88 $2.98 Million - $5.28 Million	-176,602 Reduced 27.24%	471,746 $10.7 Million
Q2 2019 Aug 14, 2019	BUY	$18.08 - $19.83 $11.7 Million - $12.9 Million	648,348 New	648,348 $12.4 Million

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.42B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.